Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
659,348
-
Share change
-
+17,349
-
Total reported value
-
$68,926,488
-
Price per share
-
$104.54
-
Number of holders
-
104
-
Value change
-
+$2,209,043
-
Number of buys
-
47
-
Number of sells
-
24
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2025
As of 31 Dec 2025,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
659,348 shares.
The largest 10 holders included
Peak Asset Management, LLC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Joseph Group Capital Management, MGB Wealth Management, LLC, DUMONT & BLAKE INVESTMENT ADVISORS LLC, and ENVESTNET ASSET MANAGEMENT INC.
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.